Detection of minimal gastric cancer cells in peritoneal washings by focused microarray analysis with multiple markers: Clinical implications

Annals of Surgical Oncology

Volumn 14, Issue 5, 2007, Pages 1694-1702

  Mori, Kazuhiko ^a,e   Suzuki, Tomohiro ^b   Uozaki, Hiroshi ^a   Nakanishi, Hayao ^c   Ueda, Tetsuya ^a   Matsuno, Yoshihiro ^f   Kodera, Yasuhiro ^d   Sakamoto, Hiromi ^e   Yamamoto, Nobuko ^b   Sasako, Mitsuru ^f   Kaminishi, Michio ^a   Sasaki, Hiroki ^e  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANON INC   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Gastric cancer; MASPIN; Microarray; Peritoneal cytology; RT PCR

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; CK20 ANTIBODY; FABP1 ANTIBODY; MASPIN ANTIBODY; MUCIN 2 ANTIBODY; TFF1 ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER CELL; CANCER DIAGNOSIS; CONTROLLED STUDY; DNA MICROARRAY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRIDIZATION; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MARKER GENE; MICROARRAY ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER;

CYTODIAGNOSIS; FATTY ACID-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; KERATIN-20; MUCINS; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SERPINS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 34249102912     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9321-4     Document Type: Article

References (21)

1. Ferlay J, Bray F, Pisani P, et al. Globocan 2000: Cancer Incidence, Mortality, and Prevalence Worldwide. Ver 1.0, vol 5. Lyon: IARC Press, 2001
2. Wu CW, Lo SS, Shen KH, et al. Incidence and factors associated with recurrence patterns after intended curative surgery for gastric cancer. World J Surg 2003;27:153-8
3. Bonenkamp JJ, Songun I, Hermans J, et al. Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg 1996;83:672-4
4. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 2nd English ed. Gastric Cancer 1998;1:10-24
5. Onate-Ocana LF, Gallardo-Rincon D, Aiello-Crocifoglio V, et al. The role of pretherapeutic laparoscopy in the selection of treatment for patients with gastric carcinoma: a proposal for a laparoscopic staging system. Ann Surg Oncol 2001;8:624-31
6. Yano M, Yasuda T, Fujiwara Y, et al. Preoperative intraperitoneal chemotherapy for patients with serosa-infiltrating gastric cancer. J Surg Oncol 2004;88:39-43
7. Kodera Y, Nakanishi H, Ito S, et al. Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse transcriptase-polymerase chain reaction. Ann Surg 2002;235:499-506
8. Fujimura T, Ohta T, Kitagawa H, et al. Trypsinogen expression and early detection for peritoneal dissemination in gastric cancer. J Surg Oncol 1998;69:71-5
9. Benevolo M, Mottolese M, Cosimelli M, et al. Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer. J Clin Oncol 1998;16:3406-11
10. Nagao K, Hisatomi H, Hirata H, et al. Expression of molecular marker genes in various types of normal tissue: implication for detection of micrometastases. Int J Mol Med 2002;10:307-10
11. Kubota K, Nakanishi H, Hiki N, et al. Quantitative detection of micrometastases in the lymph nodes of gastric cancer patients with real-time RT-PCR: a comparative study with immunohistochemistry. Int J Cancer 2003;105:136-43
12. Mori K, Aoyagi K, Ueda T, et al. Highly specific marker genes for detecting minimal gastric cancer cells in cytology negative peritoneal washings. Biochem Biophys Res Commun 2004;313:931-7
13. Taback B, Chan AD, Kuo CT, et al. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Cancer Res 2001;61:8845-50
14. Okamoto T, Suzuki T, Yamamoto N. Microarray fabricaton with covalent attachment of DNA using Bubble Jet technology. Nat Biotech 2000;18:438-41
15. Ushijima T, Sasako M. Focus on gastric cancer. Cancer Cell 2004;5:121-5
16. Ishigami S, Natsugoe S, Tokuda K, et al. Clinical impact of micrometastasis of the lymph node in gastric cancer. Am Surg 2003;69:573-7
17. Mattano LA Jr, Moss TJ, Emerson SG. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 1992;52:4701-5
18. Sakakura C, Takemura M, Hagiwara A, et al. Overexpression of dopa decarboxylase in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastases with real-time RT-PCR. Br J Cancer 2004;90:665-71
19. Wang ZN, Xu HM, Jiang L, et al. Expression of survivin in primary and metastatic gastric cancer cells obtained by laser capture microdissection. World J Gastroenterol 2004;10:3094-8
20. Harstrick A, Klaassen U, Eberhardt W, et al. Role of chemotherapy against micrometastatic cancer. Cancer Metastasis Rev 1999;18:151-72
21. Day RS, Shackney SE, Peters WP. The analysis of relapse-free survival curves: implications for evaluating intensive systemic adjuvant treatment regimens for breast cancer. Br J Cancer 2005;92:47-54